Antihypertensive medication withholding practices in hemodialysis: A survey study of patients and providers.
Antihypertensive medication withholding practices in hemodialysis: A survey study of patients and providers.
复制标题
血液透析中的抗高血压药物扣留实践:对患者和提供者的调查研究。
DOI:
10.1111/hdi.12640
复制
发表时间:
2018
期刊:
影响因子:
--
通讯作者:
Chang,TaraI
中科院分区:
文献类型:
--
作者:
Haase,SarahB;Chang,Steven;Schiller,Brigitte;Chertow,GlennM;Chang,TaraI
Most patients receiving hemodialysis have hypertension (HTN) requiring antihypertensive medications1, but treatment can be limited by intradialytic hypotension (IDH). To minimize IDH, patients are often told to withhold antihypertensive medications prior to hemodialysis; 2, 3, despite little evidence that doing so reduces the occurrence of IDH. Moreover, it could lead to longer periods of uncontrolled hypertension2. We surveyed patients receiving hemodialysis and dialysis care providers to better understand current antihypertensive medication-timing practice patterns.From September 2016 through January 2017, English-speaking patients receiving dialysis in a medium-sized dialysis organization in Northern California, who took at least one antihypertensive medication were asked to complete the anonymous survey (administered by a research team member). Anonymous surveys were sent electronically to dialysis care providers and paper surveys were distributed to providers at local meetings. All provider surveys were self-administered. We used SAS 9.4 (Cary, NC) for all analyses. A p-value< 0.05 was considered statistically significant. The study was approved by the Stanford Institutional Review Board and a Waiver of Documentation of consent was granted.